Clostridium difficile-associated infection: A disease of varying severity

American Journal of Surgery

Volumn 204, Issue 6, 2012, Pages 836-842

  Jawa, Randeep S ^a   Mercer, David W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Antibiotics; Clostridium difficile; Colitis; Diarrhea; Thomas Orr lecture

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CHLORHEXIDINE; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; CYTOTOXIN; ERYTHROMYCIN; FIDAXOMICIN; FUSIDIC ACID; GLUTAMINE; HYPERTENSIVE AGENT; METRONIDAZOLE; NITAZOXANIDE; OXIDOREDUCTASE; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RIFAMPICIN; RIFAXIMIN; TEICOPLANIN; VANCOMYCIN;

ABDOMEN; ABDOMINAL PAIN; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CELLULITIS; CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COLITIS; COLON PERFORATION; COLON RESECTION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CYTOTOXICITY TEST; DEATH; DIAGNOSTIC TEST ACCURACY STUDY; DIARRHEA; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG INDICATION; ENZYME IMMUNOASSAY; FECES CULTURE; GASTROINTESTINAL DISEASE; GOLD STANDARD; HAND WASHING; HOSPITAL HYGIENE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RATE; INTERMETHOD COMPARISON; LABORATORY TEST; LENGTH OF STAY; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MEGACOLON; MORTALITY; MULTIPLE ORGAN FAILURE; NASOGASTRIC TUBE; NONHUMAN; NORTH AMERICAN PULSED FIELD GEL ELECTROPHORESIS 1 STRAIN; PELVIS; PERITONITIS; PNEUMONIA; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMEMBRANOUS COLITIS; PULSED FIELD GEL ELECTROPHORESIS; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; RESTRICTION ENDONUCLEASE PATTERN B1 NAP 1 STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; SINGLE DRUG DOSE; SURGICAL GLOVE; SYSTEMATIC REVIEW (TOPIC); TOXIN ANALYSIS; TREATMENT DURATION; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ASYMPTOMATIC INFECTIONS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLECTOMY; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INCIDENCE; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES; VIRULENCE;

EID: 84870990937     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.05.025     Document Type: Article

References (44)

1. I. Hall, E. O'Toole Intestinal flora in newborn infants with description of a new pathogenic anaerobe Am J Dis Child 49 1935 390 402
2. H.E. Larson, J.V. Parry, A.B. Price Undescribed toxin in pseudomembranous colitis Br Med J 1 1977 1246 1248
3. J.G. Bartlett, T.W. Chang, M. Gurwith Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia N Engl J Med 298 1978 531 534
4. S. Khanna, D.S. Pardi The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings Expert Rev Gastroenterol Hepatol 4 2010 409 416
5. M. Salazar, L. Baskin, K.W. Garey Clostridium difficile-related death rates in Texas 1999-2005 J Infect 59 2009 303 307
6. D. Gravel, M. Miller, A. Simor Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program study Clin Infect Dis 48 2009 568 576
7. L.J. LaHatte, F.J. Tedesco, B.M. Schuman Antibiotic associated injury to the gut W.S. Haubrich, Bockus Gastroenterology 5th ed. 1995 WB Saunders Philadelphia 1657 1671
8. J.G. Bartlett Clostridium difficile: progress and challenges Ann N Y Acad Sci 1213 2010 62 69
9. J. Pépin, L. Valiquette, M.E. Alary Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity CMAJ 171 2004 466 472
10. L.C. McDonald, M. Owings, D.B. Jernigan Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 Emerg Infect Dis 12 2006 409 415
11. M. Rupnik, M.H. Wilcox, D.N. Gerding Clostridium difficile infection: new developments in epidemiology and pathogenesis Nat Rev Microbiol 7 2009 526 536
12. S. Khanna, D.S. Pardi, S.L. Aronson The epidemiology of community-acquired Clostridium difficile infection: a population-based study Am J Gastroenterol 107 2012 89 95
13. S. Dial, K. Alrasadi, C. Manoukian Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies CMAJ 171 2004 33 38
14. L.C. McDonald, G.E. Killgore, A. Thompson An epidemic, toxin gene-variant strain of Clostridium difficile N Engl J Med 353 2005 2433 2441
15. M. Miller, D. Gravel, M. Mulvey Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality Clin Infect Dis 50 2010 194 201
16. M. Kachrimanidou, N. Malisiovas Clostridium difficile infection: a comprehensive review Crit Rev Microbiol 37 2011 178 187
17. J.G. Bartlett Clinical practice Antibiotic-associated diarrhea N Engl J Med 346 2002 334 339
18. L.V. McFarland, J.E. Bauwens, S.A. Melcher Ciprofloxacin-associated Clostridium difficile disease Lancet 346 1995 977 978
19. J.G. Bartlett Detection of Clostridium difficile infection Infect Control Hosp Epidemiol 31 Suppl 1 2010 S35 S37
20. C.P. Kelly, J.T. LaMont Clostridium difficile infection Annu Rev Med 49 1998 375 390
21. L.V. McFarland, J.E. Clarridge, H.W. Beneda Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system Clin Infect Dis 45 2007 1141 1151
22. B.A. Jobe, A. Grasley, K.E. Deveney Clostridium difficile colitis: an increasing hospital-acquired illness Am J Surg 169 1995 480 483
23. C.R. Clabots, S. Johnson, M.M. Olson Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection J Infect Dis 166 1992 561 567
24. L.V. McFarland, M.E. Mulligan, R.Y. Kwok Nosocomial acquisition of Clostridium difficile infection N Engl J Med 320 1989 204 210
25. J.S. Fordtran Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial Proc (Bayl Univ Med Cent) 19 2006 3 12
26. Y. Carter, D. Barry Tackling C difficile with environmental cleaning Nurs Times 107 2011 22 25
27. S.H. Cohen, D.N. Gerding, S. Johnson Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Infect Control Hosp Epidemiol 31 2010 431 455
28. R.M. Dallal, B.G. Harbrecht, A.J. Boujoukas Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications Ann Surg 235 2002 363 372
29. A.D. Olivas, K. Umanskiy, B. Zuckerbraun Avoiding colectomy during surgical management of fulminant Clostridium difficile colitis Surg Infect (Larchmt) 11 2010 299 305
30. L. Kyne, C. Merry, B. O'Connell Factors associated with prolonged symptoms and severe disease due to Clostridium difficile Age Ageing 28 1999 107 113
31. S. Nair, D. Yadav, M. Corpuz Clostridium difficile colitis: factors influencing treatment failure and relapse - a prospective evaluation Am J Gastroenterol 93 1998 1873 1876
32. B.W. Hurley, C.C. Nguyen The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea Arch Intern Med 162 2002 2177 2184
33. P.J. Klingler, P.P. Metzger, M.H. Seelig Clostridium difficile infection: risk factors, medical and surgical management Dig Dis 18 2000 147 160
34. F.J. Tedesco, J.K. Corless, R.E. Brownstein Rectal sparing in antibiotic-associated pseudomembranous colitis: a prospective study Gastroenterology 83 1982 1259 1260
35. R.L. Nelson, P. Kelsey, H. Leeman Antibiotic treatment for Clostridium difficile-associated diarrhea in adults Cochrane Database Syst Rev 9 2011 CD004610
36. D.M. Drekonja, M. Butler, R. MacDonald Comparative effectiveness of Clostridium difficile treatments: a systematic review Ann Intern Med 155 2011 839 847
37. T.J. Louie, M.A. Miller, K.M. Mullane Fidaxomicin versus vancomycin for Clostridium difficile infection N Engl J Med 364 2011 422 431
38. J.S. Bakken Fecal bacteriotherapy for recurrent Clostridium difficile infection Anaerobe 15 2009 295 299
39. S.D. Malnick, O. Zimhony Treatment of Clostridium difficile-associated diarrhea Ann Pharmacother 36 2002 1767 1775
40. P. Butala, C.M. Divino Surgical aspects of fulminant Clostridium difficile colitis Am J Surg 200 2010 131 135
41. M.R. Jaber, S. Olafsson, W.L. Fung Clinical review of the management of fulminant Clostridium difficile infection Am J Gastroenterol 103 2008 3195 3203
42. W.E. Longo, J.E. Mazuski, K.S. Virgo Outcome after colectomy for Clostridium difficile colitis Dis Colon Rectum 47 2004 1620 1626
43. K. Koss, M.A. Clark, D.S. Sanders The outcome of surgery in fulminant Clostridium difficile colitis Colorectal Dis 8 2006 149 154
44. M.D. Neal, J.C. Alverdy, D.E. Hall Diverting loop ileostomy and colonic lavage: an alternative to total abdominal colectomy for the treatment of severe, complicated Clostridium difficile associated disease Ann Surg 254 2011 423 427